Author

C. S. M. Bilynsky

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

E. C. Wayne· 2 shared C. Brown· 1 shared C. Hunyh· 1 shared D. Aldarondo· 1 shared J. Kitchin· 1 shared L. Dickey· 1 shared M. Gainey· 1 shared S. Young· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

E. C. Wayne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJun 29, 2023

Nanoparticle endocytosis is driven by monocyte phenotype rather than nanoparticle size under high shear flow conditions

D. Aldarondo, C. Hunyh, L. Dickey…·E. C. Wayne

This study shows that monocyte nanoparticle endocytosis under high shear flow depends on monocyte phenotype rather than nanoparticle size, with ACE2-deficient cells preferring 100nm particles in atherosclerotic conditions.

DOI 10.1101/2023.06.29.547038

humanexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintJun 29, 2023

Meta-analysis of macrophage nanoparticle targeting across blood and solid tumors using an eLDA Topic modeling Machine Learning approach

C. Brown, C. S. M. Bilynsky, M. Gainey…·E. C. Wayne

This study uses topic modeling to analyze nanoparticle targeting of macrophages in tumors over 20 years, identifying 6 topics and trends in nanoparticle usage and therapeutic strategies.

DOI 10.1101/2023.06.29.547096

machine learning (classical)benchmarking

𝕏 PostBluesky